<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04725513</url>
  </required_header>
  <id_info>
    <org_study_id>2021P000025</org_study_id>
    <nct_id>NCT04725513</nct_id>
  </id_info>
  <brief_title>Pilot Investigation to Evaluate Effectiveness of Shockwave Therapy, Photobiomodulation and Physical Therapy in the Management of Non-insertional Achilles Tendinopathy</brief_title>
  <official_title>Pilot Investigation to Evaluate Effectiveness of Shockwave Therapy, a Combination of Shockwave Therapy and Photobiomodulation and Physical Therapy in the Management of Non-insertional Achilles Tendinopathy: A Randomized Control Trial With Elective Cross-Over Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spaulding Rehabilitation Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized control trial with an elective cross over after three months to evaluate&#xD;
      three different treatments in the management of non-insertional Achilles Tendinopathy. The&#xD;
      treatment methods include physical therapy, shockwave therapy and photobiomodulation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized control study with an elective cross over. In part 1 of the study&#xD;
      participants will be randomized into one of three treatment arms: 1) physical therapy only;&#xD;
      2) physical therapy and shockwave therapy; 3) physical therapy, shockwave therapy and&#xD;
      photobiomodulation. At 3 months, patients can choose to switch to a different treatment arm&#xD;
      than they were initially randomized.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The first part of the study is a randomized control trial, the second part is an elective cross over</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Calf raises to fatigue</measure>
    <time_frame>0-6 months</time_frame>
    <description>The number of calf raises to fatigue that the participant is able to be performed by will be recorded at different time points</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ultrasound measurements</measure>
    <time_frame>0-6 months</time_frame>
    <description>The cross-sectional area will be measure on the ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Victorian Institute of Sports Assessment (VISA-A) Questionnaire</measure>
    <time_frame>0-6 months</time_frame>
    <description>Victorian Institute of Sports Assessment Questionnaire. The score of the questionnaire ranges from 0-100, where 100 is a person who is completely asymptomatic (better).</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Achilles Tendinopathy</condition>
  <arm_group>
    <arm_group_label>Physical Therapy Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Shockwave Therapy and Physical Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Photobiomodulation, Shockwave Therapy and Physical Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Shockwave Therapy</intervention_name>
    <description>Participants will receive shockwave therapy once a week for three weeks</description>
    <arm_group_label>Photobiomodulation, Shockwave Therapy and Physical Therapy</arm_group_label>
    <arm_group_label>Shockwave Therapy and Physical Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Photobiomodulation Therapy</intervention_name>
    <description>Participants will receive photobiomodulation therapy twice a week for three weeks</description>
    <arm_group_label>Photobiomodulation, Shockwave Therapy and Physical Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Therapy</intervention_name>
    <description>Participants will enroll in physical therapy and complete an at-home exercise protocol</description>
    <arm_group_label>Photobiomodulation, Shockwave Therapy and Physical Therapy</arm_group_label>
    <arm_group_label>Physical Therapy Only</arm_group_label>
    <arm_group_label>Shockwave Therapy and Physical Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A diagnosis of mid-portion Achilles tendinopathy (including both unilateral and&#xD;
             bilateral)&#xD;
&#xD;
          -  Running is the pre-injury primary form of physical activity and pre-injury would&#xD;
             complete on average 10 miles per week or more of running&#xD;
&#xD;
          -  VISA-A &lt;80 at baseline to be eligible&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Less than 3 months of symptoms&#xD;
&#xD;
          -  Primary insertional Achilles tendinopathy&#xD;
&#xD;
          -  Diagnosis of rheumatological disease/connective tissue condition, symptomatic&#xD;
             arthritis of foot and ankle, a primary running related injury outside Achilles&#xD;
             tendinopathy, other contraindications to PBMT or SWT&#xD;
&#xD;
          -  Have received SWT within the past 3 months to their Achilles&#xD;
&#xD;
          -  Prior injection within 3 months&#xD;
&#xD;
          -  Currently enrolled in PT for more than 4 weeks for their condition&#xD;
&#xD;
          -  Women who are pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Adam Tenforde, MD</last_name>
    <phone>617-952-6808</phone>
    <email>atenforde@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katie Vogel</last_name>
    <phone>6177242168</phone>
    <email>wellmancrc@partners.org</email>
  </overall_contact_backup>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 14, 2021</study_first_submitted>
  <study_first_submitted_qc>January 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spaulding Rehabilitation Hospital</investigator_affiliation>
    <investigator_full_name>Adam S. Tenforde, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

